-
1
page
-
Français
-
Documents
-
2006
Description
Posted on Oct 18 2006 To assess the expected benefit of the unilateral or bilateral injection of botulinum toxin A (BTX) into the axillary cavity. This procedure is used to treat hyperhidrosis resistant to local treatment when the psychological and social impact is severe. HAS assessed the expected benefit of this procedure with a view to issuing an opinion on (i) its inclusion on the reimbursement list (Social Security Code, article L.162-1-7), (ii) its conditions of use. Posted on Oct 18 2006
-
Publié par
-
Publié le
01 octobre 2006
-
Licence :
Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique -
Langue
Français